Increased EphA6 expression has been described as a poor independent prognostic factor in breast cancer [19] and has been associated with disease progression in prostate cancer patients [20], where it might be implicated in angiogenesis and vascular invasion. This evidence concerns the gene EPHA6 and prostate carcinoma.